Allston Landing ships Cerezyme; Pfizer tries carrots;

> Genzyme has resumed shipping vials of Cerezyme manufactured at its Allston Landing plant. Announcement

> Carrot cells are the heart of a deal between Pfizer and Protalix for a fast-tracked orphan drug for Gaucher's disease. Release

> Novartis, with help from the US Department of Health and Human Services, has opened a large-scale flu cell culture and adjuvant manufacturing plant in North Carolina. Release

> ProMetic will develop a Mimetic Ligand affinity adsorbent as well as associated process conditions for the manufacturing of an unnamed client's recombinant biopharmaceutical product. Announcement

> A pass-through unit made of type 304 or 316 electropolished stainless steel with chrome plated latches comes with monolithic gasket that allows for steam cleaning. Release

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.